欧美日韩成人在线,337P粉嫩日本亚洲大胆艺术,色综合久久久无码中文字幕波多,麻豆人妻少妇精品无码专区

產(chǎn)品推薦：氣相|液相|光譜|質(zhì)譜|電化學(xué)|元素分析|水分測(cè)定儀|樣品前處理|試驗(yàn)機(jī)|培養(yǎng)箱


化工儀器網(wǎng)>技術(shù)中心>報(bào)價(jià)單>正文

歡迎聯(lián)系我

有什么可以幫您？ 在線咨詢

matriksbiotek2024年價(jià)格表-上海起發(fā)

  • 資料類型

    xlsx

  • 文件大小

    630.8KB

  • 瀏覽次數(shù)

    334次

  • 上傳時(shí)間

    2024年03月04日
關(guān)鍵詞
matriksbiotek,Matriks Biotek®,KLONART®,S
上傳者
上海起發(fā)實(shí)驗(yàn)試劑有限公司
立即下載

資料簡(jiǎn)介

matriksbiotek2024年價(jià)格表

Matriks Biotek專門生產(chǎn)針對(duì)抗體藥的ELISA試劑盒，用于檢測(cè)抗體藥的體內(nèi)含量或因用于產(chǎn)生的針對(duì)相應(yīng)抗體藥的抗體的體內(nèi)含量。Matriks Biotek®, SHIKARI®和KLONART®為Matriks生物技術(shù)公司注冊(cè)的產(chǎn)品商標(biāo)。其產(chǎn)品達(dá)到ISO 13485 & CE IVD標(biāo)準(zhǔn)。

MatriksBiote抗體藥是一類相對(duì)新型的生物制劑。檢測(cè)抗體藥及其抗體水平在治療和個(gè)性化用藥上具有重要意義。大量的臨床和制藥公司都在致力于抗體藥物的濃度水平和療效的研究。

特別告知：為保證產(chǎn)品質(zhì)量與良好性能，所以在購(gòu)買相應(yīng)產(chǎn)品的同時(shí)我司會(huì)收取一定量的運(yùn)輸費(fèi)用！！！本次報(bào)價(jià)有效時(shí)間為2024年1月8日---2024年12月14日。

貨號(hào)品名規(guī)格價(jià)格品牌貨期價(jià)格來(lái)源
ABA-FD-OREAbatacept (Orencia®) Free drug96T13541.38 matriksbiotek3-4周上海起發(fā)
ABA-QLS-OREAbatacept (Orencia®) Antibody screening - Qualitative96T13541.38 matriksbiotek3-4周上海起發(fā)
ABA-QNS-OREAbatacept (Orencia®) Antibody screening - Quantitative96T13541.38 matriksbiotek3-4周上海起發(fā)
ADA-FD-HUMAdalimumab (Humira®) Free drug96T11834.48 matriksbiotek3-4周上海起發(fā)
ADA-QLS-HUMAdalimumab (Humira®) Antibody screening - Qualitative96T11834.48 matriksbiotek3-4周上海起發(fā)
ADA-QNFT-HUMAdalimumab (Humira®) Antibody screening - Free/Total semiquantitative96T12289.66 matriksbiotek3-4周上海起發(fā)
ADA-QNS-HUMAdalimumab (Humira®) Antibody screening - Quantitative96T12289.66 matriksbiotek3-4周上海起發(fā)
ADA-SPEC-ADAAdalimumab (Humira®) Free drug / Specific96T12289.66 matriksbiotek3-4周上海起發(fā)
AFL-FD-EYLAflibercept (Eylea®) Free drug96T12289.66 matriksbiotek3-4周上海起發(fā)
AFL-FD-SENS-EYLAflibercept (Eylea®) Free drug96T12289.66 matriksbiotek3-4周上海起發(fā)
AFL-QLS-EYLAflibercept (Eylea®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發(fā)
AFL-QNS-EYLAflibercept (Eylea®) Antibody screening - Quantitative96T12289.66 matriksbiotek3-4周上海起發(fā)
ATE-FD-TECAtezolizumab (Tecentriq®) Free drug96T12289.66 matriksbiotek3-4周上海起發(fā)
ATE-QLS-TECAtezolizumab (Tecentriq®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發(fā)
BEV-FD-AABevacizumab (Avastin®) Free drug96T11834.48 matriksbiotek3-4周上海起發(fā)
CAN-FD-ILACanakinumab (Ilaris®) Free drug96T12289.66 matriksbiotek3-4周上海起發(fā)
CAN-QLS-ILACanakinumab (Ilaris®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發(fā)
CAN-QNS-ILACanakinumab (Ilaris®) Antibody screening - Quantitative96T12289.66 matriksbiotek3-4周上海起發(fā)
DAR-FD-DARDaratumumab (Darzalex®) Free drug96T12289.66 matriksbiotek3-4周上海起發(fā)
DAR-QLS-DARDaratumumab (Darzalex®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發(fā)
DEN-QNS-PRODenosumab (Prolia®) Antibody screening - Quantitative96T13541.38 matriksbiotek3-4周上海起發(fā)
DUR-FD-IMFDurvalumab (Imfinzi®) Free drug96T12289.66 matriksbiotek3-4周上海起發(fā)
DUR-QLS-IMFDurvalumab (Imfinzi®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發(fā)
ETA-FD-ENBEtanercept (Enbrel®) Free drug96T11834.48 matriksbiotek3-4周上海起發(fā)
EVO-FD-REPEvolocumab (Repatha® ) Free drug96T13541.38 matriksbiotek3-4周上海起發(fā)
EVO-QLS-REPEvolocumab (Repatha® ) Antibody screening - Qualitative96T13541.38 matriksbiotek3-4周上海起發(fā)
INF-FD-REMIInfliximab (Remicade®) Free drug96T11834.48 matriksbiotek3-4周上海起發(fā)
INF-FD-REMSInfliximab (Remsima®) Free drug96T11834.48 matriksbiotek3-4周上海起發(fā)
INF-QLS-REMIInfliximab (Remicade®) Antibody screening - Qualitative96T11834.48 matriksbiotek3-4周上海起發(fā)
INF-QLS-REMSInfliximab (Remsima®) Antibody screening - Qualitative96T11834.48 matriksbiotek3-4周上海起發(fā)
INF-QNFT-REMIInfliximab (Remicade®) Antibody screening - Free/Total semiquantitative96T12289.66 matriksbiotek3-4周上海起發(fā)
INF-QNFT-REMSInfliximab (Remsima®) Antibody screening - Total semiquantitative96T12289.66 matriksbiotek3-4周上海起發(fā)
INF-QNS-REMIInfliximab (Remicade®) Antibody screening - Quantitative96T12289.66 matriksbiotek3-4周上海起發(fā)
INF-QNS-REMSInfliximab (Remsima®) Antibody screening - Quantitative96T12289.66 matriksbiotek3-4周上海起發(fā)
INF-SPEC-INFInfliximab (Remicade®) Free drug / Specific96T12289.66 matriksbiotek3-4周上海起發(fā)
NIV-FD-OPDNivolumab (Opdivo®) Free drug96T12289.66 matriksbiotek3-4周上海起發(fā)
PAL-FD-SYNPalivizumab (Synagis® ) Free drug96T13541.38 matriksbiotek3-4周上海起發(fā)
PAL-QLS-SYNPalivizumab (Synagis® ) Antibody screening - Qualitative96T13541.38 matriksbiotek3-4周上海起發(fā)
PAL-QNS-SYNPalivizumab (Synagis® ) Antibody screening - Quantitative96T13541.38 matriksbiotek3-4周上海起發(fā)
PEM-FD-KEYPembrolizumab (Keytruda®) Free drug96T12289.66 matriksbiotek3-4周上海起發(fā)
RAN-FD-LUCRanibizumab (Lucentis®) Free drug96T12289.66 matriksbiotek3-4周上海起發(fā)
RIT-FD-RMRituximab (Rituxan®, Mabthera®) Free drug96T12289.66 matriksbiotek3-4周上海起發(fā)
RIT-QLS-RMRituximab (Rituxan®, Mabthera®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發(fā)
RIT-QNS-RMRituximab (Rituxan®, Mabthera®) Antibody screening - Quantitative96T12289.66 matriksbiotek3-4周上海起發(fā)
SEC-FD-VERSecukinumab (Cosentyx® , Verxant®) Free drug96T12289.66 matriksbiotek3-4周上海起發(fā)
SEC-QLS-VERSecukinumab (Cosentyx® , Verxant®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發(fā)
TOC-QNS-ACTTocilizumab (Actemra®) Antibody screening - Quantitative96T11834.48 matriksbiotek3-4周上海起發(fā)
TRA-FD-HHTrastuzumab (Herceptin®, Herclon®) Free drug96T11834.48 matriksbiotek3-4周上海起發(fā)
UST-QLS-STEUstekinumab (Stelara®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發(fā)
VED-FD-ENTVedolizumab (Entyvio®) Free drug96T12289.66 matriksbiotek3-4周上海起發(fā)
VED-QLS-ENTVedolizumab (Entyvio®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發(fā)


（*此為部分產(chǎn)品價(jià)格完整價(jià)格請(qǐng)下載文件）


關(guān)鍵詞：matriksbiotek、Matriks Biotek®、KLONART®、SHIKARI®、ELISA試劑盒

免責(zé)聲明

  • 凡本網(wǎng)注明“來(lái)源：化工儀器網(wǎng)”的所有作品，均為浙江興旺寶明通網(wǎng)絡(luò)有限公司-化工儀器網(wǎng)合法擁有版權(quán)或有權(quán)使用的作品，未經(jīng)本網(wǎng)授權(quán)不得轉(zhuǎn)載、摘編或利用其他方式使用上述作品。已經(jīng)本網(wǎng)授權(quán)使用作品的，應(yīng)在授權(quán)范圍內(nèi)使用，并注明“來(lái)源：化工儀器網(wǎng)”。違反上述聲明者，本網(wǎng)將追究其相關(guān)法律責(zé)任。
  • 本網(wǎng)轉(zhuǎn)載并注明自其他來(lái)源（非化工儀器網(wǎng)）的作品，目的在于傳遞更多信息，并不代表本網(wǎng)贊同其觀點(diǎn)和對(duì)其真實(shí)性負(fù)責(zé)，不承擔(dān)此類作品侵權(quán)行為的直接責(zé)任及連帶責(zé)任。其他媒體、網(wǎng)站或個(gè)人從本網(wǎng)轉(zhuǎn)載時(shí)，必須保留本網(wǎng)注明的作品第一來(lái)源，并自負(fù)版權(quán)等法律責(zé)任。
  • 如涉及作品內(nèi)容、版權(quán)等問(wèn)題，請(qǐng)?jiān)谧髌钒l(fā)表之日起一周內(nèi)與本網(wǎng)聯(lián)系，否則視為放棄相關(guān)權(quán)利。
企業(yè)未開通此功能
詳詢客服 : 0571-87858618